 Sebastian Obrzut
|
| Title | Clinical Professor |
|---|
| Institution | University of California San Diego |
|---|
| Department | Radiology |
|---|
| Address | 200 W. Arbor Drive #8758
San Diego CA 92103
|
|---|
| Phone | 858-657-6650 |
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | Georgetown University | Doctor of Medicine | | School of Medicine | | Rensselaer Polytechnic Institute | BS, Biomedical Engineering | | |
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Nguyen BJ, Burt A, Baldassare RL, Smitaman E, Morshedi M, Kao S, Chang EY, Obrzut S. The prognostic and diagnostic value of 18F-FDG PET/CT for assessment of symptomatic osteoarthritis. Nucl Med Commun. 2018 Jul; 39(7):699-706. PMID: 29893752.
-
Obrzut S, McCammack K, Badran KW, Balistreri A, Ou E, Nguyen BJ, Hoh CK, Rose SC. Prognostic value of post-Yttrium 90 radioembolization therapy 18F-fluorodeoxyglucose positron emission tomography in patients with liver tumors. Clin Imaging. 2017 Mar - Apr; 42:43-49. PMID: 27875761.
-
Chen L, Tiongson JE, Obrzut S, McDaniel MB, Chang HY, Patel J, Friedman PJ, Feld GK, Birgersdotter-Green UM. Standard chest radiograph predicts left ventricular lead location in chronic resynchronization therapy patients more accurately than intraoperative fluoroscopy. J Interv Card Electrophysiol. 2012 Dec; 35(3):323-30. PMID: 22843127.
-
Obrzut S, Bykowski J, Badran K, Hayeri MR, Hoh CK. Utility of fluorodeoxyglucose-positron emission tomography in the identification of new lesions in lung cancer patients for the assessment of therapy response. Nucl Med Commun. 2010 Dec; 31(12):1008-15. PMID: 20926977.
-
Obrzut S, Tiongson J, Jamshidi N, Phan HM, Hoh C, Birgersdotter-Green U. Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy. J Cardiovasc Transl Res. 2010 Dec; 3(6):643-51. PMID: 20842468; PMCID: PMC2993897.
-
Obrzut S, Jamshidi N, Karimi A, Birgersdotter-Green U, Hoh C. Imaging and modeling of myocardial metabolism. J Cardiovasc Transl Res. 2010 Aug; 3(4):384-96. PMID: 20559785; PMCID: PMC2899022.
-
Lee JK, Obrzut S, Yi ES, Deftos LJ, Bouvet M. Incidental finding of metastatic papillary thyroid carcinoma in a patient with primary hyperparathyroidism. Endocr Pract. 2007 Jul-Aug; 13(4):380-3. PMID: 17669714.
-
Obrzut S, Pham RH, Vera DR, Badran K, Hoha CK. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET. Nucl Med Commun. 2007 Jan; 28(1):7-13. PMID: 17159543.
-
Obrzut S, Koren AO, Mandelkern MA, Brody AL, Hoh CK, London ED. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. Nucl Med Biol. 2005 Nov; 32(8):869-74. PMID: 16253812.
-
Ghodsian M, Obrzut S, Hyde CC, Watts WJ, Schiepers C. Evaluation of metastatic meningioma with 2-deoxy-2-[18F]fluoro-D-glucose PET/CT. Clin Nucl Med. 2005 Nov; 30(11):717-20. PMID: 16237292.
-
Allen-Auerbach M, Quon A, Weber WA, Obrzut S, Crawford T, Silverman DH, Ratib O, Phelps ME, Czernin J. Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol. 2004 Nov-Dec; 6(6):411-6. PMID: 15564152.
-
Obrzut S, Halpern BS, Monchamp T, Grabski K, Watts WJ, Czernin J. The role of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic tumor. Mol Imaging Biol. 2004 May-Jun; 6(3):126-30. PMID: 15193246.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share related concepts with this person. _
|